A Phase III trial to assess the efficacy and safety of Boswellia serrata cream in Psoriasis
- Conditions
- Health Condition 1: null- Subjects with mild to moderate Psoriasis
- Registration Number
- CTRI/2013/09/004030
- Lead Sponsor
- Sami labs Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
1 Informed Signed consent form
2 Patients aged 18 to 65 years
3 Patients with Mild to moderate Psoriasis
1 Patients who have more than 50 percent of body surface area covered by psoriasis lesions
2 Patients on anticoagulant therapy
3 Use of immunosuppressive medication within past 2 month
4 Presence of other skin lesions like actinic ketoses or lentigo or photo damaged skin
5 Use of systemic or intralesional therapy or photo therapy for psoriasis in the previous Two months
6 Concomitant bacterial or fungal or viral skin infections
7 Pregnant or sexually active women who do not use contraception
8 Non-adherence to the treatment
9 Have history of renal or hepotobilary or malignant disease or hypertension or recurrent acute infection
10 History of any other evidence of severe illness or any other conditions that would make the patient in the opinion of the investigator unsuitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method